Title: The SBIR and STTR Programs at the National Institutes of Health
1The SBIR and STTR Programs at the National
Institutes of Health
General Information and Nuances
2Agenda
- Basics of the SBIR STTR programs
- NIH SBIR/STTR programs
- Overview
- Whats new
- Latest funding opportunities
- University participation/involvement
3Program Descriptions
- Small Business Innovation Research (SBIR)
- Set-aside program for small business
- concerns to engage in federal RD --
- with potential for commercialization.
- Small Business Technology Transfer (STTR)
- Set-aside program to facilitate cooperative
- RD between small business concerns and U.S.
research institutions -- with - potential for commercialization.
2.5
0.3
4SBIR/STTR 3-Phase Program
- PHASE I
- Feasibility Study
- 100K and 6-month (SBIR)
- or 12-month (STTR) Award
- PHASE II
- Full Research/RD
- 750K and 2-year Award
- (SBIR/STTR)
- PHASE III
- Commercialization Stage
- Use of non-SBIR/STTR Funds
5SBIR AND STTR PROGRAMSCRITICAL DIFFERENCES
- Research Partner
- SBIR Permits research institution partners
- Outsource 33 Phase I and 50
Phase II RD - STTR Requires research institution partners
(e.g., universities) - 40 small business concerns
(for-profit) and - 30 U.S. research institution
(non-profit)
AWARD ALWAYS MADE TO SMALL BUSINESS
6SBIR AND STTR PROGRAMSCRITICAL DIFFERENCES
- Principal Investigator
- SBIR Primary (gt50) employment must
be with small business concern - STTR Primary employment not stipulated
- PI can be from research institution
and/or - from small business concern
Varies Among Agencies
7SBIR PROGRAM ELIGIBILITY CHECKPOINTS
- Organized for- profit U.S. business
- At least 51 U.S.- owned and
- independently operated
- Small Business located in the U.S.
- 500 or fewer employees
- P.I.s primary employment with small
- business during project
8STTR PROGRAM ELIGIBILITY CHECKPOINTS
- Applicant is Small Business Concern
-
- Formal Cooperative RD Effort
- Minimum 40 by small business
- Minimum 30 by U.S. research institution
- U.S. Research Institution
- College or University other non-profit
research - organization Federal RD center
- Intellectual Property Agreement
- Allocation of Rights in IP and Rights to Carry
out - Follow-on RD and Commercialization
9SBIR / STTR Participating Agencies
- DOD SBIR/STTR
- HHS SBIR/STTR
- NASA SBIR/STTR
- DOE SBIR/STTR
- NSF SBIR/STTR
- DHS SBIR
- USDA SBIR
- DOC SBIR
- ED SBIR
- EPA SBIR
- DOT SBIR
New
10Were all just a little bit different ...
11Agency SBIR Differences
- Number and Timing of Solicitations
- RD Topic Areas -- (Broad vs. Focused)
- Dollar Amount of Award (Phase I and II)
- Proposal Preparation Instructions
- Financial details (e.g., Indirect Cost Rates, Gap
Funding) - Receipt Dates
- Proposal Review Process
- Proposal Success Rates
- Type of Award (Contract or Grant)
12Agency SBIR Differences
- Granting Agencies
- Investigator initiates
- approach
- Less-specified topics
- Assistance mechanism
- More flexibility
- Contracting Agencies
- Agency establishes plans,
- protocols, requirements
- Highly focused topics
- Procurement mechanism
- for DOD and NASA
- More fiscal requirements
DOD HHS/NIH NASA ED EPA DOT DOC
HHS/NIH NSF ED USDA DOE
13NIH Mission
IMPROVE HUMAN HEALTH through biomedical and
behavioral research, research training and
communications.
14Small Companies Can Help NIH meet its mission
- Conduct innovative R/RD that results in product,
process, or service that will... - Improve patient health
- Speed process of discovery
- Reduce cost of medical care/cost of
- research
- Improve research communication tools
15SBIR/STTR Participating Agencies
TOTAL 2.0 B FY 2004
- DOD SBIR/STTR
- NASA SBIR/STTR
- DOE SBIR/STTR
- NSF SBIR/STTR
- DHS SBIR
- USDA SBIR
- DOC SBIR
- ED SBIR
- EPA SBIR
- DOT SBIR
NIH 564 M SBIR 67 M STTR 631
M Total CDC 8.0 M SBIR FDA 0.8 M
SBIR AHRQ 2.1 M SBIR
16NIH SBIR/STTR FUNDING RATESFISCAL YEAR 2003
327
18
563 M SBIR/STTR (set aside 556M)
44
43
5
95
981
28
61
Success Rate ()
27
24
22
17NUANCES NIH SBIR STTR Programs
- SBIR and STTR Program
- Multiple Award Mechanisms
- Multiple Receipt Date
- Budget
- 100K/ 750K
- External Peer Review
- Critiques sent to all applicants
- Phase III
-
- Single Solicitation
- 95 Awards are grants
- April 1, Aug 1, Dec 1
- Realistic appropriate
- Academia and industry
- NIH rarely your customer
18Examples of Cross-Cutting Areas of Interest
- Nanotechnologies
- Bioinformatics
- Biodefense
- Proteomics / Genomics
- Genetically engineered proteins
- Biosensors
- Biosilicon devices
- Biocompatible materials
- Acousto-optics and opto-electronics
- Imaging technologies
- Education/communication tools
- Computational biology
- Behavioral research
19 Our Ideas
- SBIR/STTR Omnibus Grant Solicitation
- (NIH, CDC and FDA) Release January Open
for entire Calendar Year -
- SBIR Contract Solicitation (NIH, CDC)
- Release August Open for 3 months
- NIH Guide for Grants and Contracts
- Release Weekly Open as noted
-
20 Your Ideas
- Investigator-initiated RD
- Research projects related to the NIH
- mission
- Other areas of research within the
- mission of an awarding component
21SBIR/STTR Award Type
- Multiple Mechanisms
- GRANTS, Contracts, Cooperative Agreements
- Award Amount and Project Period
- Phase I 100,000 6 months
- Phase II 750,000 2 years
Realistic and appropriate
22Application Assignments
Center for Scientific ReviewReceipt Referral
Office
- Match between proposed research and ICs mission
- for funding
Match between proposed research and review groups
for scientific/technical merit
23 NIH SBIR/STTR PROGRAM Review Process for
Research Grant
Submits SBIR/STTR Grant Application to NIH
2-3 months after submission
2-3 months after review
IC Staff Prepare funding Plan for IC Director
Grantee Conducts Research
24APPLICATION, REVIEW, and AWARD TIMELINE
SBIR/STTR Scientific/Technical Adv
Council Awd Receipt Dates Peer
Review Board Review Date Apr 1
June/July Sept/Oct Nov Aug 1
Oct/Nov Jan/Feb Mar Dec 1
Feb/March May/June July
7 to 9 months
90-Day pre-award costs are allowable At your
own risk..
25REVIEW CRITERIA (Phase I)
- Significance (Real Problem/Real People)
- Approach (Research Design, Feasible)
- Innovation (New or Improved?)
- Investigators (PI and team)
- Environment (Facilities/Resources)
- Protection of Human Subjects
- Animal Welfare
- Budget
26Phase II Review Criteria
- Same as Phase I
- Demonstrated Feasibility in Phase I
- Commercialization Plan
- High Degree of Commercial Potential
- based on plan
- Protection of Human Subjects
- Animal Welfare
- Budget
27SBIR FAST-TRACK
Standard application, review, award process
Fast-Track review option
28NIH SBIR FAST-TRACK Best Option For Everyone?
No!
- Convincing preliminary data?
- Clear, measurable, achievable milestones?
- Well-conceived Commercialization Plan?
- Letters of Phase III support/interest?
- Track record for commercializing?
-
Speak with Program Staff Prior to Submission
29Whats New?
- Phase II Competing Continuations
- Technical Assistance Programs
- Executive Order 13329 Encouraging Innovation
in Manufacturing
30Phase II Competing Continuations
- Goal Provide additional research funds to move
already identified drugs or devices requiring
regulatory approval into clinical trials - Stipulations
- Available only to Phase II grantees preparing for
clinical trials - Focus -- Diagnostics, devices, tissue
engineering, drug development - Funding level 750K to 1M per year for maximum
of 3 years - IC must have announced the opportunity
Speak with Program Staff Prior to Submission
31Phase II Competing Continuations
- Omnibus
- Solicitation
- NIA
- NIDCD
- NINDS
-
- PAs RFAs
- NIMH PA-01-173
- NICHD PA-03-085
- NCI PA-04-047
- NIAAA PA-03-129
- NHLBI PA-04-028
- NIAID RFA-AI-04-005
- NIDA PA-03-154
-
32Technical Assistance Programs
Business strategic planning Builds alliances
and investor partnerships
- Commercialization
- Assistance
-
(Phase II awardees)
Identify other uses of technology Determines
competitive advantages Develops market entry
strategy
Pilot Niche Assessment
(Phase I awardees)
33Executive Order 13329
- Requires SBIR/STTR Agencies to give high
priority to manufacturing-related research and
development
relating to manufacturing processes, equipment
and systems or manufacturing workforce skills
and protection
34Latest Funding Opportunities (Samples)http//gran
ts.nih.gov/grants/funding/sbir_announcements.htm
- RFA-CA-05-006 Innovative Technologies for
Molecular Analysis of Cancer (SBIR/STTR) - PAR-03-119 Innovations in Biomedical
Computational Science and Technology - PA-04-094 Novel Technologies for In Vivo Imaging
35RFA-CA-05-006 Innovative Technologies for
Molecular Analysis of Cancer
Objective To develop highly innovative
cancer-related methods and tools that enable
research
- Unique Features
- Special receipt dates (Mar, Jun, Oct)
- Initial review convened by NCI
- Parallel in scope with RFA-CA-05-002
- Flexible budget and project durations
- Phase I 2 yrs, 100K direct costs each year
- Phase II 3 yrs, no official budget limit
- Annual meeting of investigators
36PAS-02-149 Small Business Biodefense Program
Objective To rapidly develop specific products
for biodefense
- Unique Features
- 35M set-aside in FY 2003
- Flexible budget and project durations
- Phase I 2 yrs, 500K total costs per year
- Phase II 3 yrs, 2M total costs per year
- Mandatory milestone approval of the final
clinical protocol by NIAID prior to start of
clinical trial
37University Partnerships(Provide analytical and
other service support)
- Consultants on SBIR/STTR
- Subcontracts on SBIR/STTR
- Senior Personnel on SBIR/STTR
- Principal Investigator
- (with official permission from University)
- Own small firms
- (assign someone else PI)
-
Applicant must be the small business!
38http//grants.nih.gov/grants/funding/sbir.htm
- Alerts
- Solicitations
- Targeted Research Opportunities
- Sample Application
- Award Information
- Collaborative Opportunities
- Success Stories
39 Im from the Government, and Im here to help
you.
40Jo Anne Goodnight NIH SBIR/STTR Program
Coordinator Phone 301-435-2688 Fax
301-480-0146 Email goodnigj_at_od.nih.gov Kay
Etzler SBIR/STTR Program Phone
301-435-2713 Fax 301-480-0146 Email
etzlerk_at_od.nih.gov